Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4921 - 4928 of 11617 results
The Tall Tale of the Domestic Industry
March 4, 2019| Blog| Viewpoint
SB 561 Aims to Make CCPA More Consumer-Friendly by Expanding a Private Right of Action and Removing the Right to Cure
March 4, 2019| Blog| Viewpoint
M&A bar gleans lessons from blowup of $4.75B pharma deal
March 4, 2019| News
March 2019: Where Are We Now With 340B?
March 1, 2019| Blog| Viewpoint
Energy & Sustainability Connections Newsletter – March 2019
March 1, 2019| Article| Viewpoint
Energy & Sustainability M&A Activity – March 2019
March 1, 2019| Article| Viewpoint
Energy & Sustainability Washington Updates – March 2019
March 1, 2019| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.